Watch That Paxil in Breast Cancer Applicants

Medical News: SSRI and Tamoxifen Increase Mortality Risk – in Hematology/Oncology, Breast Cancer from MedPage Today

Overlapping use of tamoxifen and the antidepressant paroxetine (Paxil) significantly increases the risk of breast cancer mortality, data from a large cohort of breast cancer patients showed.

The excess breast-cancer mortality risk ranged as high as 91%, depending on the duration of simultaneous use, researchers reported online in BMJ.

Oops.